biotech · Advanced Solid Tumor · Sjogren's Disease · CGEM
Cullinan Therapeutics
Cullinan Therapeutics trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.
Dyer St, Providence, Rhode Island 02903, US HQ
2017 Founded
7 Employees
Public company Type
CGEM · NYSE Ticker
Company details
- Status
- Public
- HQ
- Dyer St, Providence, Rhode Island 02903, US
- Founded
- 2017
- Employees
- 7
- Programs
- 16
- Drugs
- 14
- Patents
- 3
Cullinan Therapeutics clinical trials
Registry index of 16 ClinicalTrials.gov studies linked to Cullinan Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Cullinan Therapeutics trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Cullinan Therapeutics.
-
CLN-978-SL-101 — Phase 1
Clinical update -
CLN-619-001 — Phase 1
Clinical update -
CLN-049-002 — Phase 1
Clinical update -
CLN-978-SJ-101 — Phase 1
Clinical update -
CLN-978-RA-101 — Phase 1
Clinical update -
CLN-978 — Phase 1
Clinical update -
CLN-049 — Phase 1
Clinical update -
CLN-081, CLN-081 — Phase 2
Clinical update
Trial registry
-
CTIS ↗ - 2024-511744-27-00CTIS ↗
CLN-619-001
Solid tumors, Non-Small Cell Lung Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer, breast cancer, gastrointestinal cancer
- 2024-516532-97-00CTIS ↗
CLN-081, CLN-081
Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
-
CTIS ↗ -
CTIS ↗ -
CTIS ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗